Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novanta (NOVT) Gains from Sales and Divestitures (2016 - 2025)

Novanta's Gains from Sales and Divestitures history spans 14 years, with the latest figure at $94000.0 for Q4 2025.

  • For Q4 2025, Gains from Sales and Divestitures rose 91.84% year-over-year to $94000.0; the TTM value through Dec 2025 reached $94000.0, up 91.84%, while the annual FY2025 figure was $94000.0, 91.84% up from the prior year.
  • Gains from Sales and Divestitures reached $94000.0 in Q4 2025 per NOVT's latest filing, up from $53000.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $487000.0 in Q4 2021 to a low of $41000.0 in Q3 2022.
  • Average Gains from Sales and Divestitures over 5 years is $107350.0, with a median of $79000.0 recorded in 2021.
  • Peak YoY movement for Gains from Sales and Divestitures: soared 201.06% in 2021, then tumbled 91.58% in 2022.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $487000.0 in 2021, then crashed by 91.58% to $41000.0 in 2022, then surged by 70.73% to $70000.0 in 2023, then decreased by 30.0% to $49000.0 in 2024, then surged by 91.84% to $94000.0 in 2025.
  • Per Business Quant, the three most recent readings for NOVT's Gains from Sales and Divestitures are $94000.0 (Q4 2025), $53000.0 (Q3 2025), and $83000.0 (Q2 2025).